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Abstract
Background: A stressful stimulus is a crucial determinant of health and disease. Antidepressants are used to manage 
stress and their related effects. The present study was designed to investigate the effect of St. John's Wort (Hypericum 
perforatum) in restraint stress-induced behavioral and biochemical alterations in mice.
Methods: Animals were immobilized for a period of 6 hr. St. John's Wort (50 and 100 mg/kg) was administered 30 
minutes before the animals were subjecting to acute immobilized stress. Various behavioral tests parameters for 
anxiety, locomotor activity and nociceptive threshold were assessed followed by biochemical assessments 
(malondialdehyde level, glutathione, catalase, nitrite and protein) subsequently.
Results: 6-hr acute restraint stress caused severe anxiety like behavior, antinociception and impaired locomotor 
activity as compared to unstressed animals. Biochemical analyses revealed an increase in malondialdehyde, nitrites 
concentration, depletion of reduced glutathione and catalase activity as compared to unstressed animal brain. Five 
days St. John's Wort treatment in a dose of 50 mg/kg and 100 mg/kg significantly attenuated restraint stress-induced 
behavioral (improved locomotor activity, reduced tail flick latency and antianxiety like effect) and oxidative damage as 
compared to control (restraint stress).
Conclusion: Present study highlights the modest activity of St. John's Wort against acute restraint stress induced 
modification.
Background
Stress is a crucial determinant for maintenance of health
and disease [1,2]. Stress either due to internal or external
stimuli disturbs physiological homeostasis and causes
neurobehavioral alteration [3,4]. There are various neu-
r o p s y c h i a t r i c  p r o b l e m s  s u c h  a s  a n x i e t y ,  c o g n i t i v e  d y s -
function, depression etc, are generally associated with
stress. Stress induces changes in emotional behavior, anx-
iety like state [5] that are associated with oxidative dam-
age i.e. free radical damage [1,2]. Acute restraint stress
stimulates numerous cellular cascade that lead to
increase ROS production [6,7]. The central nervous sys-
tem is especially vulnerable to free radical damage
because of brain's high oxygen consumption, abundant
lipid content and relative paucity of antioxidant enzymes
[8]. Immobilization stress has also been reported to
induce 2-3 fold higher rise of plasma cortisol level.
Increase cortisol level has been linked with anxiety like
behavior [9]. It has been reported that stress triggers the
motor alteration in different animal models [10]. Previous
studies have also demonstrated that various chronic
stress triggers hyperalgesia and allodynia [10,11]. Recent
studies demonstrated that restraint stress produces anti-
nociception which is relevant to numerous painful
pathologies, such as fibromyalgia (FM), characterized by
diffuse muscular pain (hyperalgesia) and/or tenderness
(allodynia). This contention supported by the findings
* Correspondence: kumaruips@yahoo.com
1 Pharmacology Division, UGC Centre of Advance Study (UGC-CAS), University 
Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, 
India
† Contributed equally
Full list of author information is available at the end of the articleKumar et al. BMC Complementary and Alternative Medicine 2010, 10:18
http://www.biomedcentral.com/1472-6882/10/18
Page 2 of 6
that restraint stress increases pain threshold in hot-plate
test [13]. The central nucleus of amygdala (CeA) is
important in fear conditioning and in modulating affec-
tive response to stress [14-17].
St. John's Wort (Hypericum perforatum) is well known
antidepressant herbal remedy contains hypericin,
pseudohypericin, hyperforin, quercitine and quercitrin as
one of the major active constituents [18]. SJW is widely
used in the treatment of depression in many countries
and represented as an accepted alternative to synthetic
antidepressants or behavioral therapy, particularly for
mild to moderate depression [19-22]. Recently, antide-
p r e s s a n t s  h a v e  b e e n  r e p o r t e d  t o  h a v e  n e u r o p r o t e c t i v e
effect and antioxidant like effect against immobilization
stress [45]. However, their exact status in stressful condi-
tions is still not clear so far.
With this background, the present study was designed
to investigate protective effect of St. John's Wort in acute




Male Albino mice (Laca strain) weighing between 22-30 g
bred in Central Animal House facility of the Panjab Uni-
versity, Chandigarh, India were used. The animals were
housed under standard laboratory conditions and main-
tained on a 12 h light/dark cycle and had free access to
food and water. Animals were acclimatized to laboratory
conditions before the experiment. Each group consists of
minimal 5 animals. All the experiments were carried out
between 9:00 and 17:00. The experimental protocols were
approved by Institutional Animal Ethics Committee of
Panjab University, Chandigarh, India and conducted
according to the Indian National Science Academy
Guidelines for the use and care of experimental animals.
Drugs and treatment schedule
St. John's Wort (Hypericum perforatu) extract was pro-
vided by Dabur, Gaziabad, India as gift product. The
extract was water soluble. Before administration, the
extract was freshly prepared with distilled water. St.
John's Wort (50 and 100 mg/kg, i.p.) were administered
for five days and animals were subjected to restraint
stress on 6th day (Figure 1). The doses were selected based
on our previous study [23].
Restraint stress
Animals were restraint for 6-hr by taping all the four
limbs on a board after putting them on their backs using
zinc oxide hospital tape. Release was affected by unravel-
ing the tape after moistening with acetone in order to
minimize pain or discomfort. In unstr essed group, the




The nociceptive threshold was determined as the tail flick
latency elicited in response to radiant heat [25]. Baseline
latencies to tail flick withdrawal from the radiant heat
source (3-5s) were established. A cut-off time of 10s was
maintained to prevent any injury on the tail [26].
Measurement of locomotor activity
Animal was kept in actophotometer for first 3 minutes
before making actual recording in actophotometer for a
period of 5 min. The apparatus was placed in a darkened
light sound attenuated and ventilated testing room. Each
animal was observed over a period of 5 min in a square
(30 cm) closed arena equipped with infrared light sensi-
tive photocells using digital photoactometer and values
expressed as counts per 5 min [27].
Measurement of anxiety: Mirror Chamber Test
The mirror chamber consisted of a wooden chamber hav-
ing a mirror cube enclosed within it. The container box
was (40 × 40 × 30.5) cm. Animal was placed at the distal
corner of the mirror chamber at the beginning of the test.
During the 5 min test session, following parameters were
noted- a) latency to enter the mirror chamber, b) average
time spent per entry in mirror chamber. An anxiogenic
response was defined as decreased the number of entries
and time spent in the mirror chamber [26].
Biochemical parameters
All the animals were sacrificed by decapitation on the
same day immediately after behavioral assessments. The
brains were removed, rinsed in isotonic saline and
weighed. A 10% (w/v) tissue homogenates were prepared
with 0.1 M phosphate buffer (pH 7.4). The post nuclear
fractions were obtained by centrifugation of the homoge-
nate at 12000 × g for 20 min at 4°C.
Lipid peroxidation assay
The quantitative measurement of lipid peroxidation in
the whole brain was assessed as per method of Wills [28].
The amount of malondialdehyde formed was measured
by the reaction with thiobarbituric acid at 532 nm using
Perkin Elmer lambda 20 spectrophotometer. The results
were expressed as nmol of malondialdehyde per mg pro-
tein using the molar extinction coefficient of chro-
mophore (1.56 × 105 M-1 cm-1).
Estimation of reduced glutathione
Reduced glutathione (GSH) in the brain was estimated
according to the method of Ellman [29]. A 1.0 ml of
homogenate was precipitated with 1.0 ml of 4% sulfosali-
cylic acid by keeping the mixture at 4°C for 1 h and sam-
ples were immediately centrifuged at 1200 × g for 15 min
at 4°C. The assay mixture contains 0.1 ml of supernatant,
2.7 ml of phosphate buffer of pH 8.0 and 0.2 ml of 0.01 M-Kumar et al. BMC Complementary and Alternative Medicine 2010, 10:18
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dithiobisnitrobenzoic acid (DTNB). The absorbance of
the reaction product was immediately measured at 412
nm using a Perkin Elmer lambda 20 spectrophotometer.
The results were expressed as micromole GSH per mg
protein.
Nitrite estimation
Nitrite is the stable end product of nitric oxide (NO) in
living system. Accumulation of nitrite was measured in
cell free supernatants from brain homogenates by spec-
trophotometer assay based on Greiss reagent 15 (1% sul-
phanilamide/0.1% naphthylethylenediamine
dihydrochloride/2.5% phosphoric acid) and incubated at
room temperature for 10 min to yield a chromophore.
Absorbance was measured at 543 nm spectrophotometri-
cally. The nitrite concentration was calculated from a
standard curve using sodium nitrite as standard and
expressed as micro molar nitrite per ml homogenate [30].
Protein estimation
The protein content was measured according to the
method of lowry using bovine serum albumin as standard
[31].
Catalase estimation
Catalase activity was assayed by the method of Luck [32],
wherein the breakdown of hydrogen peroxide (H2O2) was
measured at 240 nm. Briefly, the assay mixture consisted
of 3 ml of H2O2 phosphate buffer, 0.05 ml of supernatant
of tissue homogenate (10%), and the change in absor-
bance was recorded at 240 nm. The results were
expressed as micromole H2O2 decomposed per mg of
protein/min.
Statistical Analysis
All the values are expressed as mean ± SEM. The data
were analyzed by using one way analysis of variance fol-
lowed by Tukey's test. P < 0.05 was considered statisti-
cally significant.
Results
Behavioral measurements (Locomotor, anxiety and 
analgesic activity)
The naïve animals showed the consistent stable locomo-
tor activity and anxiety like behavior and antinociception
effect. 6-hr acute restraint stress significantly reduced
locomotor activity (as indicated by decreased ambulatory
movements), anxiety-like behaviors (delayed latency to
enter in mirror chamber, decreased number of entries
and time spent in the mirror chamber) and increased tail
flick latency (antinociceptive like effect for first few min-
utes) as compared to unstressed (naïve) group (P < 0.05)
(Table 1). Five days St. John's Wort (50 and 100 mg/kg)
treatment significantly caused anti-anxiety-like behavior
(shortened time latency to enter in mirror chamber,
increased average time spent per entry in mirror cham-
ber) and improved locomotor activity (increased ambula-
tory movements) as compared to control (restraint stress)
animals. However, St. John's Wort treatment did not
restore the performances of stressed mice to the levels of
the naive group. However, tail flick latency was not influ-
enced significantly as compared to control (restraint
stress) animals (P < 0.05). Besides, St. John's Wort (50 and
100 mg/kg) treatment significantly produced analgesic
effect in unstressed group as compared to naïve (P < 0.05)
(Table 1).
Biochemical measurements
6-hr acute restraint stress significantly increased malond-
ialdehyde, nitrite concentration, depleted reduced gluta-
thione and catalase activity as compared to unstressed
(naïve) animals (Table 2). Five days with St. John's Wort
(50 and 100 mg/kg) treatment significantly attenuated the
rise in malondialdehyde, nitrite concentration and caused
restoration of GSH and catalase activity as compared to
the control (restraint stress) group (P < 0.05) (Table 2).
Discussion
The ability of the biological system to cope stressful con-
dition plays a crucial role in the body [33]. Stress activates
Figure 1 Kumar et al. BMC Complementary and Alternative Medicine 2010, 10:18
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hypothalamus - pituitary - adrenal axis (HPA) axis and
influences several neurological function at both central
and peripheral level. Any kind of stress influences brain
functions by causing long term changes in the multiple
neural systems [34,35]. Restraint stress has been reported
to influence motor activity, caused pain perception [37]
anxiety like behavior [36], and depression-like behaviors
[38] in the animals. In the present study, 6-hr restraint
stress significantly caused anxiety like behavior, impaired
motor activity and antinocieption, indicating stress
induced neurobehavioral alterations. Stress has already
been reported to alter neurobehavioral in both acute as
well as chronic stress [38]. Marked behavioral changes
might be due to alteration in the brain regions controlling
motor activity and anxiety like behavior. Impaired motor
activity could be due to stress induced depression. Fur-
ther, St. John's Wort treatment for five days significantly
improved behavior alterations, suggesting its neuropro-
tective effect against stressful conditions. Antidepres-
sants have been reported to alleviate stress and stress
related effects [39,40]. Recently, neuroprotective effects
of antidepressants have been reported [45]. However, sci-
entific mechanistic explanations of their clinical efficacy
for treatment of depression are not been fully understood
so far. Present study further suggests its therapeutic
potential against these stress related altered behavioral
states. Further, five days St. John's Wort treatment did not
influence significantly antinociceptive effect. This might
be due to its own analgesic effect, antianxiety and
improved locomotor activity. In the present study, St.
John's Wort treatment significantly produced analgesic
effect. Antidepressant drugs have been widely used for
many years to treat pain and related states, despite
unclear rationale of their clinical use [45]. Their mecha-
nisms of action (noradrenergic, serotonergic, opioids),
focusing on central and peripheral analgesic actions are
still not clear.





Tail flick test Mirror chamber test
(Counts/5 min) Tail flick latency
(Sec)
Latency to enter 
mirror chamber
(sec)
Average time spent 
per entry(sec)
Naïve 232 ± 1.32 1.75 ± 0.10 43.0 ± 1.08 48.75 ± 1.65
SJW(50) 239 ± 4.2 4.0 ± 1.5a 37.6 ± 3.4 46.32 ± 2.8
SJW (100) 243 ± 6.9a 5.0 ± 2.8a 34.6 ± 4.6 44.3 ± 1.6
Control (RS) 48.75 ± 1.65a 9.25 ± 0.19a 127 ± 1.95a 12.25 ± 0.85a
SJW(50)+ RS 105.25 ± 2.0b 8.15 ± 0.45a, NS 101 ± 2.3b 21.5 ± 0.83b
SJW (100)+RS 125.25 ± 1.8c 7.82 ± 0.29a, NS 78 ± 2.8c 33.75 ± 0.76c
Valu0es are expressed as Mean ± SEM. aP < 0.05 as compared to naïve. bP < 0.05 as compared to control. cP < 0.05 as compared to St. John's 
Wort (50 mg/kg). (One-Way ANOVA followed by Tukey's test). NS = Not significant, RS = Restraint Stress, SJW = St. John's Wort
Table 2: Effect of St. John's Wort on biochemical alterations on unstressed and immobilization stressed animals
Treatment (mg/kg) LPO (moles of MDA/
mgpr)







Naïve 0.112 ± 0.002 0.091 ± 0.002 254.5 ± 2.62 0.807 ± 0.003
S JW (50) 0.102 ± 0.002NS 0.094 ± 0.003NS 250.1 ± 1.58NS 0.809 ± 0.002NS
S JW (100) 0.100 ± 0.003NS 0.096 ± 0.002NS 249.5 ± 2.62NS 0.810 ± 0.002NS
Control (RS) 0.623 ± 0.006a 0.011 ± 0.0007a 653.5 ± 2.66a 0.140 ± 0.001a
S JW (50)+RS 0.340 ± 0.009b 0.034 ± 0.001b 501 ± 2.3b 0.300 ± 0.003b
S JW (100)+RS 0.190 ± 0.006c 0.064 ± 0.002c 394.75 ± 1.8c 0.465 ± 0.006c
Values are expressed as Mean ± SEM. aP < 0.05 as compared to naïve. bP < 0.05 as compared to control. cP < 0.05 as compared to St. John's 
Wort (50 mg/kg). (One-Way ANOVA followed by Tukey's test) NS = Not significant, RS = Restraint Stress, SJW = St. John's Wort, LPO = lipid 
peroxidation, MDA = malondialdehyde, GSH = reduced glutathione, mgpr = milligram proteinKumar et al. BMC Complementary and Alternative Medicine 2010, 10:18
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Oxidative stress causes cellular damage and accelerates
neuro-degeneration by inducing the reactive oxygen spe-
cies (ROS) that oxidize vital cellular components such as
lipids, proteins and DNA [41,42]. In the present study, 6-
hr immobilized stress caused significantly oxidative dam-
age as indicated by raise in lipid peroxidation, nitrite con-
centration and depletes reduced GSH and catalase
activity. Tsuboi et al reported an increased oxidative
damage and weak antioxidant defense events are impli-
cated in major depression [43]. In the present study, St.
John's Wort treatment significantly attenuated lipid per-
oxidation, nitrite concentration and partially restored
GSH and catalase activity suggesting its antioxidant like
effect. Supporting to our study, clinical trial also indicates
that raised level of MDA in patients with affective disor-
ders [44]. Besides, other antidepressant such as fluoxetine
has also been reported to reduce the maloanodialdehyde
level in restraint animals [45]. Antidepressants drugs
have also been reported to elevated antioxidant enzyme
defense system particularly superoxide enzyme and cata-
lase activity [46]. These antioxidant enzymes raised the
level of oxidative defense against stress.
Conclusion
Present study highlights the modest activity of SJW
against acute restrain stress causes neurobehavioral alter-
ations and oxidative damage. Study provides a hope SJW
can be used in the treatment and management of stress
conditions.
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